Back to Search
Start Over
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study
- Source :
- Cancer Immunology, Immunotherapy.
- Publication Year :
- 2023
- Publisher :
- Springer Science and Business Media LLC, 2023.
- Subjects :
- Cancer Research
Oncology
Immunology
Immunology and Allergy
Subjects
Details
- ISSN :
- 14320851 and 03407004
- Database :
- OpenAIRE
- Journal :
- Cancer Immunology, Immunotherapy
- Accession number :
- edsair.doi...........d073e80624dad7dc9971e9ffe0fbfa8d
- Full Text :
- https://doi.org/10.1007/s00262-023-03469-5